Teva Pharmaceutical Industries Ltd. (TEVA)
41.47
+1.50
(+3.75%)
USD |
NYSE |
Oct 29, 16:00
41.00
-0.47
(-1.13%)
Pre-Market: 09:18
Teva Pharmaceutical Industries Price : 41.47 for Oct. 29, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | 40.14 | 41.67 | 40.01 | 41.47 | 5.232M |
| Oct 28, 2026 | 39.74 | 40.50 | 39.46 | 39.97 | 4.647M |
| Oct 27, 2026 | 39.71 | 40.86 | 39.71 | 40.39 | 5.979M |
| Oct 26, 2026 | 39.22 | 40.12 | 39.15 | 39.95 | 6.032M |
| Oct 23, 2026 | 39.75 | 39.84 | 39.10 | 39.41 | 5.599M |
| Oct 22, 2026 | 40.20 | 40.44 | 39.58 | 40.21 | 4.069M |
| Oct 21, 2026 | 40.18 | 41.09 | 39.50 | 40.62 | 4.597M |
| Oct 20, 2026 | 41.48 | 41.59 | 40.80 | 40.85 | 4.224M |
| Oct 19, 2026 | 41.42 | 41.88 | 41.25 | 41.31 | 3.828M |
| Oct 16, 2026 | 41.26 | 41.70 | 40.96 | 41.50 | 5.990M |
| Oct 15, 2026 | 41.30 | 41.85 | 41.03 | 41.11 | 9.410M |
| Oct 14, 2026 | 41.11 | 41.87 | 40.71 | 40.72 | 10.27M |
| Oct 13, 2026 | 41.23 | 41.65 | 40.96 | 41.25 | 6.819M |
| Oct 12, 2026 | 41.29 | 41.49 | 40.60 | 41.17 | 7.556M |
| Oct 09, 2026 | 40.22 | 42.02 | 40.12 | 41.10 | 14.82M |
| Oct 08, 2026 | 38.84 | 39.64 | 38.25 | 39.25 | 5.823M |
| Oct 07, 2026 | 38.92 | 39.39 | 38.64 | 39.18 | 3.456M |
| Oct 06, 2026 | 39.65 | 39.93 | 38.85 | 39.13 | 5.717M |
| Oct 05, 2026 | 39.44 | 40.03 | 39.27 | 39.66 | 4.148M |
| Oct 02, 2026 | 39.31 | 39.81 | 39.05 | 39.53 | 4.775M |
| Oct 01, 2026 | 39.50 | 39.58 | 38.52 | 39.31 | 5.987M |
| Sep 30, 2026 | 40.20 | 40.28 | 39.22 | 39.60 | 5.655M |
| Sep 29, 2026 | 38.90 | 40.24 | 38.66 | 39.81 | 6.823M |
| Sep 28, 2026 | 38.36 | 39.11 | 38.30 | 38.88 | 4.307M |
| Sep 25, 2026 | 40.10 | 40.25 | 38.93 | 39.19 | 3.875M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Bristol Myers Squibb Co. | 61.39 |
| Merck & Co., Inc. | 146.33 |
| RedHill Biopharma Ltd. | 0.4166 |
| AstraZeneca PLC | 174.40 |
| Eli Lilly & Co. | 1373.70 |
Price Related Metrics
| PE Ratio | 69.73 |
| PS Ratio | 2.781 |
| Price to Book Value | 6.232 |
| Price to Free Cash Flow | 33.05 |
| Earnings Yield | 1.43% |
| Market Cap | 48.31B |
| Operating PE Ratio | 14.80 |
| Normalized PE Ratio | 26.13 |